CANB: Can B Corp. Stock

by  •  • Comments Off on CANB: Can B Corp. Stock

SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries

Valuation
Market Cap ($M) 1.49
Enterprise Value ($M) 18.71
Book Value ($M) -9.79
Book Value / Share -0.13
Price / Book -0.15
NCAV ($M) -10.05
NCAV / Share -0.13
Price / NCAV -0.15

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.49
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.12
Current Ratio 0.14

Balance Sheet (mrq) ($M)
Current Assets 1.59
Assets 1.86
Liabilities 11.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Arena Investors LP 0.20 -91.82

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REP
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT P
2024-07-17 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPOR
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT

(click for more detail)

Similar Companies
BKTSF – Beckett's Inc. BLEVF – Beleave Inc.
BLOZF – Cannabix Technologies Inc. CGRA – CGrowth Capital, Inc.
CNBI – China BCT Pharmacy Group, Inc.


Financial data and stock pages provided by
Fintel.io